Data gathered: November 30
AI Stock Analysis - Mirum Pharmaceuticals (MIRM)
Analysis generated June 8, 2024. Powered by Chat GPT.
Mirum Pharmaceuticals is a growing biopharmaceutical company focused on tackling liver diseases and other medical conditions that have limited treatment options. With a dedicated team of scientists and a robust pipeline of innovative therapies, Mirum aims to improve the lives of patients who are suffering from rare and life-threatening diseases. The company operates with a vision of individual attention, offering personalized and precise treatment options.
Stock Alerts - Mirum Pharmaceuticals (MIRM)
 |
Mirum Pharmaceuticals | November 18 Price is down by -5.8% in the last 24h. |
|
Mirum Pharmaceuticals | November 16 Insider Alert: Howe Jolanda is selling shares |
|
Mirum Pharmaceuticals | November 15 Price is down by -5.1% in the last 24h. |
|
Mirum Pharmaceuticals | November 14 Price is up by 5.4% in the last 24h. |
Alternative Data for Mirum Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 86 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | 7 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 347 | Sign up | Sign up | Sign up |
| Instagram Followers | 371 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,510 | Sign up | Sign up | Sign up |
| Twitter Followers | 567 | Sign up | Sign up | Sign up |
| Twitter Mentions | 48 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 53 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 38 | Sign up | Sign up | Sign up |
| Linkedin Employees | 331 | Sign up | Sign up | Sign up |
About Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
| Price | $46.22 |
| Target Price | Sign up |
| Volume | 206,760 |
| Market Cap | $2.24B |
| Year Range | $23.57 - $46.65 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of “Buy” by BrokeragesNovember 27 - ETF Daily News |
|
Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Down 4.6% After Insider SellingNovember 18 - ETF Daily News |
 |
Robert W. Baird Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) StockNovember 17 - ETF Daily News |
|
HC Wainwright Has Optimistic Outlook of MIRM FY2024 EarningsNovember 16 - ETF Daily News |
|
Research Analysts Offer Predictions for MIRM Q3 EarningsNovember 16 - ETF Daily News |
 |
Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter ResultsNovember 14 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 89M | 56M | 33M | -14M | -6.8M | 0.000 |
| Q2 '24 | 78M | 55M | 23M | -25M | -19M | -0.520 |
| Q1 '24 | 71M | 51M | 20M | -25M | -21M | -0.540 |
| Q4 '23 | 67M | 52M | 15M | -36M | -27M | -0.660 |
| Q3 '23 | 48M | 39M | 8.6M | -24M | -23M | -0.570 |
Insider Transactions View All
| Howe Jolanda filed to sell 2,426 shares at $47.1. November 15 '24 |
| Heron Patrick J filed to buy 162,308 shares at $37.4. September 20 '24 |
| Heron Patrick J filed to buy 162,193 shares at $41.6. September 10 '24 |
| Howe Jolanda filed to sell 2,426 shares at $34. July 3 '24 |
| Vig Pamela filed to sell 27,406 shares at $34. June 25 '24 |
Similar companies
Read more about Mirum Pharmaceuticals (MIRM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Mirum Pharmaceuticals?
The Market Cap of Mirum Pharmaceuticals is $2.24B.
What is the current stock price of Mirum Pharmaceuticals?
Currently, the price of one share of Mirum Pharmaceuticals stock is $46.22.
How can I analyze the MIRM stock price chart for investment decisions?
The MIRM stock price chart above provides a comprehensive visual representation of Mirum Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Mirum Pharmaceuticals shares. Our platform offers an up-to-date MIRM stock price chart, along with technical data analysis and alternative data insights.
Does MIRM offer dividends to its shareholders?
As of our latest update, Mirum Pharmaceuticals (MIRM) does not offer dividends to its shareholders. Investors interested in Mirum Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Mirum Pharmaceuticals?
Some of the similar stocks of Mirum Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.